Abstract:[Abstract]Objective: To explore the role of receptor tyrosine kinase Axl in the autoantibodyinduced arthritis. Methods:Both the Axldeficient mice and their littermate control wildtype mice were transferred with K/BxN serum to induce arthritis by intraperitoneal injection. Then the degree of arthritis were assessed with ankle thickness and clinical scores. At the same time, HE staining and safraninOfast green staining were carried out to detect the histological changes. In addition, ELISA was performed to determine the protein level of tumor necrosis factorα (TNFα) and interleukin 6 (IL6) in joint tissues. Furthermore, the mRNA levels of TNFα and IL6 in joint tissues and leukocytes were detected by QPCR. Results:Axl deficiency aggravated the severity of arthritis and synovial inflammation. The cartilage damage and bone erosion were severer than the control. Importantly, the levels of TNFα and IL6 were also increased significantly in joint tissues and leukocytes. Conclusion: Axl plays a protective role in autoantibodyinduced arthritis.
高亮, 阳艾珍, 武艺. 受体酪氨酸激酶Axl在自身抗体诱导关节炎发病中的作用[J]. 江苏大学学报:医学版, 2016, 26(04): 307-310,315.
GAO Liang, YANG Ai-zhen, WU Yi. Role of Axl in the autoantibodyinduced arthritis. Journal of Jiangsu University(Medicine Edition), 2016, 26(04): 307-310,315.
[1]Kouskoff V, Korganow AS, Duchatelle V, et al. Organspecific disease provoked by systemic autoimmunity \[J\]. Cell, 1996, 87(5): 811-822.[2]Holmdahl R, Malmstrm V, Burkhardt H. Autoimmune priming, tissue attack and chronic inflammationthe three stages of rheumatoid arthritis \[J\]. Eur J Immunol, 2014, 44(6): 1593-1599.[3]Ji H, Ohmura K, Mahmood U, et al. Arthritis critically dependent on innate immune system players \[J\]. Immunity, 2002, 16(2): 157-168.[4]Ditzel HJ. The K/BxN mouse: a model of human inflammatory arthritis\[J\]. Trends Mol Med, 2004, 10(1): 40-45.[5]Rothlin CV, Ghosh S, Zuniga EI, et al. TAM receptors are pleiotropic inhibitors of the innate immune response \[J\]. Cell, 2007, 131(6): 1124-1136.[6]Bassyouni IH, ElWakd MM, Azab NA, et al. Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor Axl in patients with rheumatoid arthritis \[J\]. Int J Rheum Dis, 2014, 1111/1756-185X[7]Monach PA, Mathis D, Benoist C. The K/BxN arthritis model \[J\]. Curr Protoc Immunol, 2008, Chapter 15:Unit 15.22. doi: 10.1002/0471142735.im1522s81.[8]Kim ND, Chou RC, Seung E, et al. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis \[J\]. J Exp Med, 2006, 203(4): 829-835.[9]Rose S, Waters EA, Haney CR, et al. Highresolution magnetic resonance imaging of ankle joints in murine arthritis discriminates inflammation and bone destruction in a quantifiable manner \[J\]. Arthritis Rheum, 2013, 65(9): 2279-2289.[10]Garcia S, Forteza J, LopezOtin C, et al. Matrix metalloproteinase8 deficiency increases joint inflammation and bone erosion in the K/BxN serumtransfer arthritis model \[J\]. Arthritis Res Ther, 2010, 12(6): R224.[11]D′Arcangelo D, Gaetano C, Capogrossi MC. Acidification prevents endothelial cell apoptosis by Axl activation \[J\]. Circ Res, 2002, 91(7): e4-12.[12]Fridell YW, Jin Y, Quilliam LA, et al. Differential activation of the Ras/extracellularsignalregulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase \[J\]. Mol Cell Biol, 1996, 16(1): 135-145.[13]Hafizi S, Ibraimi F, Dahlback B. C1TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration \[J\]. FASEB J, 2005, 19(8): 971-973.[14]Bellosta P, Costa M, Lin DA, et al. The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding \[J\]. Mol Cell Biol, 1995, 15(2): 614-625.[15]Liu H, Pope RM. The role of apoptosis in rheumatoid arthritis \[J\]. Curr Opin Pharmacol, 2003, 3(3): 317-322.[16]Rothlin CV, Lemke G. TAM receptor signaling and autoimmune disease \[J\]. Curr Opin Immunol, 2010, 22(6): 740-746.[17]Lemke G, Rothlin CV. Immunobiology of the TAM receptors \[J\]. Nat Rev Immunol, 2008, 8(5): 327-336.[18]Pruessmeyer J, Hess FM, Alert H, et al. Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space \[J\]. Blood, 2014, 123(26): 4077-4088.[19]Alciato F, Sainaghi PP, Sola D, et al. TNFα, IL6, and IL1 expression is inhibited by GAS6 in monocytes/macrophages \[J\]. J Leukoc Biol, 2010, 87(5): 869-875.[20]Ji H, Pettit A, Ohmura K, et al. Critical roles for interleukin 1 and tumor necrosis factor α in antibodyinduced arthritis \[J\]. J Exp Med, 2002, 196(1): 77-85.[21]Blom AB, Radstake TR, Holthuysen AE, et al. Increased expression of Fcγ receptors Ⅱ and Ⅲ on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor α and matrix metalloproteinase \[J\]. Arthritis Rheum, 2003, 48(4): 1002-1014.[22]Mancardi DA, Jonsson F, Iannascoli B, et al. Cutting Edge: The murine highaffinity IgG receptor FcγRⅣ is sufficient for autoantibodyinduced arthritis \[J\]. J Immunol, 2011, 186(4): 1899-1903.[23]AbdollahiRoodsaz S, Koenders MI, Walgreen B, et al. Tolllike receptor 2 controls acute immune complexdriven arthritis in mice by regulating the inhibitory Fcγ receptor ⅡB \[J\]. Arthritis Rheum, 2013, 65(10): 2583-2593.[24]Godau J, Heller T, Hawlisch H, et al. C5a initiates the inflammatory cascade in immune complex peritonitis \[J\]. J Immunol, 2004, 173(5): 3437-3445.